CERINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 92
AS - Asia 57
EU - Europa 36
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 12
AF - Africa 2
Totale 217
Nazione #
US - Stati Uniti d'America 89
IT - Italia 30
BD - Bangladesh 19
SG - Singapore 17
BR - Brasile 10
CN - Cina 8
VN - Vietnam 7
HK - Hong Kong 4
PL - Polonia 4
CA - Canada 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
FR - Francia 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
NI - Nicaragua 1
PY - Paraguay 1
ZA - Sudafrica 1
Totale 199
Città #
San Jose 21
Ashburn 20
Council Bluffs 8
Santa Clara 6
Singapore 6
Beijing 5
Milan 5
Bari 3
Dallas 3
Ho Chi Minh City 3
Hong Kong 3
Los Angeles 3
Bologna 2
Chicago 2
Hanoi 2
Krakow 2
Miano 2
New York 2
Orem 2
Warsaw 2
Americus 1
Arezzo 1
Arujá 1
Baghdad 1
Balsas 1
Barranquilla 1
Barretos 1
Boardman 1
Buffalo 1
Bắc Ninh 1
Cassano delle Murge 1
Copenhagen 1
Dhaka 1
Durban 1
Evarts 1
Goldsboro 1
Jacksonville 1
Jersey City 1
Lakeland 1
Managua 1
Montreal 1
Nairobi 1
Palo del Colle 1
Petrolina 1
Quixeramobim 1
Rome 1
Roseau 1
Salvador 1
San Francisco 1
Santo Inácio do Piauí 1
Sassuolo 1
Seattle 1
São Miguel do Oeste 1
São Paulo 1
Terlizzi 1
Tokyo 1
Upper Marlboro 1
Videira 1
Woodbridge 1
Totale 141
Nome #
Role of copper chelating agents: between old applications and new perspectives in neuroscience 81
2- Aryloxymethylene-substituted scaffolds as privileged moieties for the design of new potential metal chelators in the multi-target therapy of Alzheimer's disease 29
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment 24
Improved 2-aryloxymethylene moieties as novel potential chelators for the multi-target treatment of Alzheimer’s disease 21
Leveraging nature as source of potential anti-Alzheimer’s drugs: The NInFA project 15
A sustainable and semi-synthetic strategy for the discovery of novel multi-target anti-Alzheimer's agents 14
Enhanced chelating agent with multi-target activity potentially useful for the treatment of Alzheimer’s Disease 9
Evaluation of the effects of halogens on the anti-cholinesterase activity of potent multi-targeted hybrids designed for the treatment of Alzheimer's disease 9
Synthesis and preliminary pharmacological characterization of novel fibrate derivatives as PPAR agonists for the prospective management of metabolic dysfunction-associated disorders 9
Lead optimization of rivastigmine-like hybrids: Impact of nitro group and halogen substitution on multi-target anti-Alzheimer's activity 6
Totale 217
Categoria #
all - tutte 755
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 755


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 0 0 1 3
2024/202518 1 0 5 2 1 0 1 2 0 0 3 3
2025/2026139 5 2 2 11 17 8 6 6 14 19 45 4
2026/202756 8 23 25 0 0 0 0 0 0 0 0 0
Totale 217